A nationwide newborn screening program introduced in Sweden detected all salt-wasting congenital adrenal hyperplasia cases between 1986 and 2011, according to a study in the journal JAMA Pediatrics. The neonatal testing had a sensitivity rate of 84.3% for all forms of CAH and resulted in low recall rates for full-term and preterm babies.

Related Summaries